COMISA care pathway in cancer treatment
Official title: ONC-SLEEP Collaborative: COMISA Collaborative Care Integration in Oncology
Funded at Wayne State University · NIH-11440898 · Data updated 2026-11-12
A team at Wayne State University is testing a simple, clinic-based plan to screen cancer patients for sleep problems and connect them quickly with care for insomnia and sleep apnea.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wayne State University NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project start | August 14, 2026 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $398,544 |
| NIH project number | 1R21CA318809-01 |
| Project ID | NIH-11440898 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with cancer who experience sleep problems or have risk factors for COMISA.
✕Less likely to help
Patients without sleep symptoms or those not reachable through clinic-based care pathways may not benefit.
What this research studies
Many cancer patients struggle with sleep problems that hurt their daily functioning and recovery. This project builds a team-based care pathway in oncology clinics to screen all patients, refer them to a care manager, and use home sleep tests and proven therapies like CBT-I and PAP devices when needed. It uses a small registry to track who is screened, who starts treatment, and who needs extra help so teams can adjust in real time. The aim is to make sleep care a routine part of cancer care, improving energy, mood, and overall recovery.
Why it matters
Potential benefit: If successful, patients with cancer may experience better sleep, more energy, and improved quality of life during and after treatment.
How similar studies have gone: Past work shows that integrated sleep care can improve sleep and daytime function in various populations, but this project applies a cancer-specific, clinic-based CoCM approach to COMISA.
Where this research is happening
-
Wayne State University
Detroit, United States Active
Researchers
- Principal investigator: Al Achkar, Morhaf — Wayne State University
- Study coordinator: Al Achkar, Morhaf
Related research
Other NIH-funded projects on the same topics.
-
New MRI tools to better plan pediatric epilepsy surgery
A new MRI-based approach helps doctors decide the best time to surgically remove brain tissue in children with difficult-to-control seizures.
-
EBV reactivation and how it changes human cells in HIV-related cancers
This NIH grant looks at how Epstein-Barr virus reactivation affects human cells and may contribute to cancers in people with HIV/AIDS.
-
Programmed splicing derangement and EBV host cell shut-off in HIV/ AIDS-related cancers
Researchers are studying how Epstein-Barr virus reprograms human cells in people with HIV/AIDS to promote cancer development and autoimmune diseases.
-
PFAS may speed up artery disease by changing bile acids
Aims to see if PFAS chemicals make cholesterol rise and arteries more likely to harden, using a human-similar mouse model to understand how this could affect people.
-
Synthesis and measurement of cyanotoxins to understand human exposure from water and air
This project will make precise chemical standards and measurement methods for cyanotoxins from harmful algal blooms to better estimate how people might be exposed through drinking water and air.
-
Personalized cancer subtyping and risk prediction with multi-omics data
A cancer research project aims to classify tumors and predict risk by integrating multiple molecular data types to tailor treatments for patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.